NCT01623245View on ClinicalTrials.gov

Prevalence of Transthyretin Amyloidosis in Hypertrophic Cardiomyopathy

CompletedOBSERVATIONAL
Enrollment

294

Participants

Timeline

Start Date

June 30, 2012

Primary Completion Date

December 31, 2014

Study Completion Date

December 31, 2014

Conditions
Cardiac AmyloidosisAmyloidosis in Transthyretin (TTR)Hypertrophic Cardiomyopathy (HCM)
Trial Locations (1)

94000

Henri Mondor Hospital, Créteil

All Listed Sponsors
lead

Thibaud Damy

OTHER

NCT01623245 - Prevalence of Transthyretin Amyloidosis in Hypertrophic Cardiomyopathy | Biotech Hunter | Biotech Hunter